Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Non-Current Assets (2019 - 2025)

Korro Bio's Other Non-Current Assets history spans 7 years, with the latest figure at $2.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 11.62% year-over-year to $2.5 million, compared with a TTM value of $2.5 million through Dec 2025, down 11.62%, and an annual FY2025 reading of $2.5 million, down 11.62% over the prior year.
  • Other Non-Current Assets for Q4 2025 was $2.5 million at Korro Bio, down from $3.2 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $3.2 million in Q2 2025, with the low at $228000.0 in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $2.1 million, with a median of $2.0 million recorded in 2023.
  • Year-over-year, Other Non-Current Assets crashed 86.58% in 2022 and then surged 1090.35% in 2023.
  • Tracing KRRO's Other Non-Current Assets over 5 years: stood at $1.7 million in 2021, then tumbled by 86.58% to $228000.0 in 2022, then surged by 1090.35% to $2.7 million in 2023, then increased by 3.06% to $2.8 million in 2024, then dropped by 11.62% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Other Non-Current Assets are $2.5 million (Q4 2025), $3.2 million (Q3 2025), and $3.2 million (Q2 2025).